Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132373) titled 'Mixed formulation of fosrolapitant and palonosetron ± Dexamethasone in Combination with Prochlorperazine in Preventing Highly Emetogenic Anticancer Drugs-induced Nausea and Vomiting' on Sept. 14.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Yaan People's Hospital
Condition:
anti-cancer therap-induced nausea and vomiting
Intervention:
cohort 2:Mixed formulation of fosrolapitant and palonosetron + olanzapine
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-17
Target Sample Size: cohort 2:177;cohort 1:177;
Countries of Recru...